Paper39335641
Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance.
Matsumoto H and 9 others. Biomedicines, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. Papers, record 39335641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39335641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28858073 | The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future. | Inflamm Bowel Dis | 2017 | https://conductscience.org/library/papers/28858073 | PubMed |
| 2 | 28486648 | Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. | J Crohns Colitis | 2017 | https://conductscience.org/library/papers/28486648 | PubMed |
| 3 | 37534095 | Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients. | J Clin Biochem Nutr | 2023 | https://conductscience.org/library/papers/37534095 | PubMed |
| 4 | 32526207 | Personalized Mapping of Drug Metabolism by the Human Gut Microbiome. | Cell | 2020 | https://conductscience.org/library/papers/32526207 | PubMed |
| 5 | 26727498 | Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice. | PLoS One | 2016 | https://conductscience.org/library/papers/26727498 | PubMed |
| 6 | 26541610 | Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. | Science | 2015 | https://conductscience.org/library/papers/26541610 | PubMed |
| 7 | 35546404 | Regulatory role of short-chain fatty acids in inflammatory bowel disease. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/35546404 | PubMed |
| 8 | 30644982 | Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. | JAMA | 2019 | https://conductscience.org/library/papers/30644982 | PubMed |
| 9 | 29429045 | Evidence-based clinical practice guidelines for inflammatory bowel disease. | J Gastroenterol | 2018 | https://conductscience.org/library/papers/29429045 | PubMed |
| 10 | 22933715 | Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/22933715 | PubMed |
| 11 | 29173524 | Fecal Transplant in Inflammatory Bowel Disease. | Gastroenterol Clin North Am | 2017 | https://conductscience.org/library/papers/29173524 | PubMed |
| 12 | 34880489 | Combinatorial, additive and dose-dependent drug-microbiome associations. | Nature | 2021 | https://conductscience.org/library/papers/34880489 | PubMed |
| 13 | 30576644 | AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30576644 | PubMed |
| 14 | 28813664 | Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice. | Cell Rep | 2017 | https://conductscience.org/library/papers/28813664 | PubMed |
| 15 | 35901721 | Alteration of the Gut Microbiome in Inflammatory Bowel Disease. | Digestion | 2023 | https://conductscience.org/library/papers/35901721 | PubMed |
| 16 | 30467977 | Differential clustering of fecal and mucosa-associated microbiota in 'healthy' individuals. | J Dig Dis | 2018 | https://conductscience.org/library/papers/30467977 | PubMed |
| 17 | 25061070 | STAMP: statistical analysis of taxonomic and functional profiles. | Bioinformatics | 2014 | https://conductscience.org/library/papers/25061070 | PubMed |
| 18 | 32013315 | 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. | Intest Res | 2020 | https://conductscience.org/library/papers/32013315 | PubMed |
| 19 | 28672320 | Fecal Microbiota Transplantation. | JAMA | 2017 | https://conductscience.org/library/papers/28672320 | PubMed |
| 20 | 30301334 | 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis. | Intest Res | 2018 | https://conductscience.org/library/papers/30301334 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41788674 | Mosla chinensis maxim. essential oil ameliorates DSS-induced colitis and enhances the intestinal barrier via the PI3K-AKT signaling pathway. | Front Nutr | 2026 | https://conductscience.org/library/papers/41788674 | PubMed |
| 41631162 | Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis. | JGH Open | 2026 | https://conductscience.org/library/papers/41631162 | PubMed |
| 41153785 | Mechanisms for Precision, Patient-Centered Therapy in Inflammatory Bowel Disease. | Biomedicines | 2025 | https://conductscience.org/library/papers/41153785 | PubMed |
| 40869289 | Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869289 | PubMed |
| 40563369 | Inactivated Cells and Metabolites of Saccharomyces boulardii Alleviate Inflammation Damage in Caco-2 Monolayer Cells and Mice with Ulcerative Colitis. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563369 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39335641
GET https://conductscience.org/api/papers/v1/39335641/references?page=2